基因表达特征作为肝细胞癌常规活检中微血管侵犯的替代标志物
本研究旨在定义与肝细胞癌微血管侵犯相关的转录组特征,可应用于福尔马林固定石蜡包埋活检。使用NanoString技术在178例FFPE肝细胞癌样本中识别出6基因特征,训练集准确率82%,验证集活检预测准确率74%,且该特征与总生存相关。
要点
- 6基因特征(ROS1、UGT2B7、FAS、ANGPTL7、GMNN、MKI67)可预测FFPE肝细胞癌活检中的微血管侵犯。
- 训练集准确率82%(敏感度82%,特异度81%,AUC 0.82),验证集活检准确率74%(敏感度73%,特异度76%,AUC 0.74)。
- 该特征与总生存相关(HR 2.29;95%CI 1.03-5.07;p=0.041),但生存影响需进一步研究确认。
核心结论
- 定义了6基因特征,可在FFPE肝细胞癌活检样本中准确预测微血管侵犯,并与总生存相关。
研究设计与样本
- 利用NanoString技术,基于文献和150例冷冻肝细胞癌样本的RNA测序数据选择200个基因。
- 使用178例FFPE肝细胞癌样本,包括109例手术样本作为训练集和69例配对术前活检作为验证集。
主要发现
- 训练集手术样本中6基因特征与微血管侵犯强相关,准确率82%(敏感度82%,特异度81%,AUC 0.82)。
- 14对手术/活检样本中NanoString基因表达高度相关(平均R:0.97)。
- 验证集69例FFPE活检中,6基因特征预测微血管侵犯准确率74%(敏感度73%,特异度76%,AUC 0.74)。
- 多因素分析显示,微血管侵犯特征在两组中均与总生存相关(风险比2.29;95%CI 1.03-5.07;p=0.041)。
关键数值与推荐
- 6基因特征包含ROS1、UGT2B7、FAS、ANGPTL7、GMNN、MKI67。
- 训练集准确率82%(敏感度82%,特异度81%,AUC 0.82)。
- 验证集活检准确率74%(敏感度73%,特异度76%,AUC 0.74)。
- 总生存风险比2.29(95%CI 1.03-5.07;p=0.041)。
临床怎么用
- 该特征可应用于常规肿瘤活检,辅助预测微血管侵犯并整合到治疗策略中。
局限性
- 生存影响需通过更大规模研究及更多临床数据确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Microvascular invasion (MVI), a major risk factor for tumor recurrence after surgery in hepatocellular carcinoma (HCC), is only detectable by microscopic examination of the surgical specimen. We aimed to define a transcriptomic signature associated with MVI in HCC than can be applied to formalin-fixed paraffin-embedded (FFPE) biopsies for use in clinical practice. METHODS: To identify a gene expression signature related to MVI by using NanoString technology, we selected a set of 200 genes according to the literature and RNA-sequencing data obtained from a cohort of 150 frozen HCC samples previously published. We used 178 FFPE-archived HCC samples, including 109 surgical samples for the training set and 69 paired pre-operative biopsies for the validation set. In 14 cases of the training set, a paired biopsy was available and was also analyzed. RESULTS: We identified a 6-gene signature (ROS1, UGT2B7, FAS, ANGPTL7, GMNN, MKI67) strongly associated with MVI in the training set of FFPE surgical HCC samples, with 82% accuracy (sensitivity 82%, specificity 81%, AUC 0.82). The NanoString gene expression was highly correlated in 14 paired surgical/biopsy HCC samples (mean R: 0.97). In the validation set of 69 FFPE HCC biopsies, the 6-gene NanoString signature predicted MVI with 74% accuracy (sensitivity 73%, specificity 76%, AUC 0.74). Moreover, on multivariate analysis, the MVI signature was associated with overall survival in both sets (hazard ratio 2.29; 95% CI 1.03-5.07; p = 0.041). CONCLUSION: We defined a 6-gene signature that can accurately predict MVI in FFPE HCC biopsy samples, which is also associated with overall survival, although its survival impact must be confirmed by extensive study with further clinical data. LAY SUMMARY: Microvascular invasion, a major risk factor for tumor recurrence after surgery in hepatocellular carcinoma, is only detectable by microscopic examination of a surgical specimen. In this study, we defined a relevant surrogate signature of microvascular invasion in hepatocellular carcinoma that may be applied in clinical practice with routine tumor biopsy and integrated into the therapeutic strategy.
引用
- Beaufrère A, Caruso S, Calderaro J, et al. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol. 2021. PMID: 34624411. doi:10.1016/j.jhep.2021.09.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。